184 related articles for article (PubMed ID: 1517805)
1. Effect of intra-arterial cisplatin and 1,3-bis(2chloroethyl)-1-nitrosourea (BCNU) dosage on radiographic response and regional toxicity in malignant glioma patients: proposal of a new method of intra-arterial dosage calculation.
Bobo H; Kapp JP; Vance R
J Neurooncol; 1992 Jul; 13(3):291-9. PubMed ID: 1517805
[TBL] [Abstract][Full Text] [Related]
2. Supraophthalmic carotid infusion for recurrent glioma: rationale, technique, and preliminary results for cisplatin and BCNU.
Kapp JP; Vance RB
J Neurooncol; 1985; 3(1):5-11. PubMed ID: 2987427
[TBL] [Abstract][Full Text] [Related]
3. Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4'-O-demethyl-1-O-(4,6-O-2-thenylidene-beta-D-glucopyranosyl) epipodophyllotoxin (VM-26) in the treatment of primary and metastatic brain tumors.
Stewart DJ; Grahovac Z; Benoit B; Addison D; Richard MT; Dennery J; Hugenholtz H; Russell N; Peterson E; Maroun JA
Neurosurgery; 1984 Dec; 15(6):828-33. PubMed ID: 6392925
[TBL] [Abstract][Full Text] [Related]
4. Intracarotid chemotherapy with 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma.
Johnson DW; Parkinson D; Wolpert SM; Kasdon DL; Kwan ES; Laucella M; Anderson ML
Neurosurgery; 1987 Apr; 20(4):577-83. PubMed ID: 3587550
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy of malignant gliomas: studies of the BTCG.
Shapiro WR
Rev Neurol (Paris); 1992; 148(6-7):428-34. PubMed ID: 1448662
[TBL] [Abstract][Full Text] [Related]
6. Neurological deficit after carotid infusion of cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) for malignant glioma: an analysis of risk factors.
Kapp JP; Sanford RA
Neurosurgery; 1986 Nov; 19(5):779-83. PubMed ID: 3785625
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of supratentorial glioma with intracarotid cisplatin and intravenous carmustine].
Rebollo J; Martín-Algarra S; Bilbao I; Zubieta JL; Calvo FA; de Castro P; Pastor MA; Viteri C; Martínez Lage JM
Neurologia; 1990; 5(7):228-32. PubMed ID: 1963067
[TBL] [Abstract][Full Text] [Related]
8. A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma.
Shapiro WR; Green SB; Burger PC; Selker RG; VanGilder JC; Robertson JT; Mealey J; Ransohff J; Mahaley MS
J Neurosurg; 1992 May; 76(5):772-81. PubMed ID: 1564540
[TBL] [Abstract][Full Text] [Related]
9. Treatment of recurrent brain tumors with intra-arterial cis-platinum and BCNU.
Kapp JP; Vance R
J Miss State Med Assoc; 1984 Jan; 25(1):1-6. PubMed ID: 6325705
[No Abstract] [Full Text] [Related]
10. Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.
Rajkumar SV; Buckner JC; Schomberg PJ; Pitot HC; Ingle JN; Cascino TL
Neurosurgery; 1999 Jan; 44(1):67-73. PubMed ID: 9894965
[TBL] [Abstract][Full Text] [Related]
11. Selective intra-arterial chemotherapy with BCNU in recurrent malignant gliomas.
Bradac GB; Soffietti R; Riva A; Stura G; Sales S; Schiffer D
Neuroradiology; 1992; 34(1):73-6. PubMed ID: 1313161
[TBL] [Abstract][Full Text] [Related]
12. Limitations of high dose intra-arterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) chemotherapy for malignant gliomas.
Kapp J; Vance R; Parker JL; Smith RR
Neurosurgery; 1982 Jun; 10(6 Pt 1):715-9. PubMed ID: 7110545
[No Abstract] [Full Text] [Related]
13. Experiences with sodium thiosulfate after intracarotid infusion of cisplatin and BCNU for malignant gliomas.
Vance RB; Pittisapu J; Kapp JP
J Neurooncol; 1986; 4(2):151-4. PubMed ID: 3783209
[TBL] [Abstract][Full Text] [Related]
14. Supraophthalmic carotid infusion with low dose cisplatin and BCNU for malignant glioma.
Vance RB; Kapp JP
J Neurooncol; 1986; 3(4):287-90. PubMed ID: 3958775
[TBL] [Abstract][Full Text] [Related]
15. Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system.
Greenberg HS; Ensminger WD; Chandler WF; Layton PB; Junck L; Knake J; Vine AK
J Neurosurg; 1984 Sep; 61(3):423-9. PubMed ID: 6747681
[TBL] [Abstract][Full Text] [Related]
16. Phase-I trial of intracarotid BCNU and cisplatin in patients with malignant intracerebral tumors.
Feun LG; Wallace S; Yung WK; Lee YY; Leavens ME; Moser R; Savaraj N; Burgess MA; Plager C; Benjamin RS
Cancer Drug Deliv; 1984; 1(3):239-45. PubMed ID: 6544123
[TBL] [Abstract][Full Text] [Related]
17. Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy.
Raizer JJ; Malkin MG; Kleber M; Abrey LE
Neuro Oncol; 2004 Jul; 6(3):247-52. PubMed ID: 15279717
[TBL] [Abstract][Full Text] [Related]
18. Intra-arterial mannitol infusion in the chemotherapy for malignant brain tumors.
Iwadate Y; Namba H; Saegusa T; Sueyoshi K
J Neurooncol; 1993 Feb; 15(2):185-93. PubMed ID: 8509823
[TBL] [Abstract][Full Text] [Related]
19. Superselective cerebral arterial infusion of BCNU in high-grade glioma: the radiologist's point of view.
Fontaine S; Théron J; Melanson D; Villemure JG; Emrich J; Raymond J; Ethier R
Can Assoc Radiol J; 1988 Sep; 39(3):178-81. PubMed ID: 2971050
[TBL] [Abstract][Full Text] [Related]
20. Combined intraarterial and systemic chemotherapy for intracerebral tumors.
Stewart DJ; Grahovac Z; Hugenholtz H; Russell N; Richard M; Benoit B
Neurosurgery; 1987 Aug; 21(2):207-14. PubMed ID: 2443873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
